Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesOxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Reviews, 10/09/09
Koch MW et al. – Oxcarbazepine and carbamazepine appear to be similarly effective and well tolerated. However, the possibility of important differences existing between these drugs cannot be ruled out.
Related Articles
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials
Epilepsia, 10/29/09
Relevance Score: 80%
Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2)
Acta Neurologica Scandinavica, 10/16/09
Relevance Score: 79%
Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09
Relevance Score: 66%
Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy
Neuropsychiatric Disease and Treatment, 10/20/09
Relevance Score: 66%
Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy
Acta Neurologica Scandinavica, 10/22/09
Relevance Score: 65%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Neuroimaging to assess safety and efficacy of AD therapies
Expert Opinion on Investigational Drugs, 12/09/09
Sponsor
Article Search
Sponsor